The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADVFN Regulatory News (AFN)

Share Price Information for ADVFN (AFN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.50
Bid: 10.00
Ask: 11.00
Change: 0.00 (0.00%)
Spread: 1.00 (10.00%)
Open: 10.50
High: 10.50
Low: 10.50
Prev. Close: 10.50
AFN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ADFVN connects audience to Doceo content

21 Sep 2023 12:00

RNS Number : 2377N
ADVFN PLC
21 September 2023
 

News release

 

September 21st, 2023

 

ADVFN connects its audience to Doceo fund manager content

 

ADVFN is delighted to announce a partnership with Doceo to bring greater transparency to investors seeking top quality data and insights on financial markets and investments. Doceo videos feature fund managers and business leaders updating investors on strategy, positioning, and performance. The content is now available on ADVFN supplementing the market-leading financial tools and granular data already on the platform.

 

This partnership aims to provide a richer picture of the investment landscape for self-directed investors. The collaboration coincides with calls for greater access to investment research materials for retail investors, and increasing share ownership amongst the retail investor community.

 

Sam Buchanan, Managing Director at Doceo said: "ADVFN has a leading track record in delivering reliable financial data to an increasingly important group of investors, and the incorporation of Doceo's digestible and detailed updates directly from the underlying decision makers is an important step in our shared ambition to bring requisite investment information to all."

 

Matthew Collom, Sales Director at ADVFN, said: "Doceo fund manager content is a fantastic addition to ADVFN's comprehensive portfolio. It will provide ADVFN users with invaluable insights from industry leaders and further help them in their investment decisions."

 

Contacts:

Doceo: Sam Buchanan | sam.buchanan@doceo.tv

ADVFN: Matthew Collom | matthewc@advfnplc.com

 

Notes to Editors:

 

ADVFN:

 

ADVFN is an award-winning global stocks, shares and crypto information website providing market-leading financial tools and data to private investors around the world. Offering real-time share prices, news feeds, charting, portfolio management, monitor lists, financials, data from global stock exchanges, Level 2 and the most active financial bulletin board in the UK (along with many other features), the site is the destination of choice for day traders and retail investors.

 

Doceo

 

Doceo provides self-directed and professional investors with timely, regular access to investment insights. Short format, curated video interviews with investment decision makers improve transparency within the investment process and provide investors with the tools they need to make informed decisions within their portfolios.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAENFALADEFA
Date   Source Headline
21st Mar 20249:49 amRNSHalf-year Report
9th Feb 202411:19 amRNSNew ADVFN Italia website is launched
12th Jan 20242:00 pmRNSResult of Meeting
28th Dec 20231:10 pmRNSResult of AGM
21st Dec 20237:00 amRNSFinal Results
5th Dec 20234:00 pmRNSNotice of AGM
16th Nov 20231:30 pmRNSHolding(s) in Company
21st Sep 202312:00 pmRNSADFVN connects audience to Doceo content
15th Aug 20236:05 pmRNSCorporate update
9th Jun 20236:15 pmRNSDirector/PDMR Shareholding
2nd Jun 202312:14 pmRNSTrading and corporate update
16th May 20234:33 pmRNSHolding(s) in Company
5th May 20233:06 pmRNSTotal Voting Rights
4th Apr 20237:00 amRNSIssue of Equity
30th Mar 20232:07 pmRNSHolding(s) in Company
30th Mar 20232:05 pmRNSHolding(s) in Company
23rd Mar 20235:02 pmRNSHolding(s) in Company
23rd Mar 20235:01 pmRNSHolding(s) in Company
23rd Mar 20235:00 pmRNSHolding(s) in Company
23rd Mar 20233:30 pmRNSDirector/PDMR Shareholding
20th Mar 20236:20 pmRNSAdmission update
14th Mar 202312:05 pmRNSFurther equity issue under the Open Offer
6th Mar 20237:00 amRNSHalf-year Report
6th Feb 202311:53 amRNSDirectorate Change
13th Jan 202311:19 amRNSResult of AGM
11th Jan 20231:15 pmRNSHolding(s) in Company
11th Jan 202311:10 amRNSHolding(s) in Company
11th Jan 202311:10 amRNSHolding(s) in Company
11th Jan 202310:49 amRNSHolding(s) in Company
11th Jan 202310:49 amRNSHolding(s) in Company
10th Jan 20237:00 amRNSCorporate update
9th Jan 20235:22 pmRNSTotal voting rights, Director / PDMR shareholding
6th Jan 20232:04 pmRNSFinal Results of Open Offer
6th Jan 20237:00 amRNSResults of Open Offer
20th Dec 20227:00 amRNSOpen Offer timetable and AGM
6th Dec 20227:00 amRNSOpen Offer
6th Dec 20227:00 amRNSFinal Results
28th Nov 20227:00 amRNSCorporate update
15th Sep 202210:45 amRNSAppointment of joint corporate broker
19th Aug 20224:15 pmRNSCorporate update
8th Aug 20227:00 amRNSDirectorate Change
6th Jun 20227:00 amRNSTrading and Corporate Update
29th Apr 20222:05 pmRNSResult of Meeting
28th Apr 20224:41 pmRNSSecond Price Monitoring Extn
28th Apr 20224:35 pmRNSPrice Monitoring Extension
28th Apr 20222:01 pmRNSHolding(s) in Company
22nd Apr 20224:00 pmRNSTotal Voting Rights
20th Apr 202211:05 amRNSSecond Price Monitoring Extn
20th Apr 202211:00 amRNSPrice Monitoring Extension
13th Apr 20229:29 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.